IMMEDIATE OPEN ACCESS ARTICLE
J Med Microbiol 57 (2008), 690-696; DOI: 10.1099/jmm.0.47742-0
© 2008 Society for General Microbiology
ISSN 1473-5644
Processing of Clostridium difficile toxins
Torsten Giesemann,
Martina Egerer,
Thomas Jank and
Klaus Aktories
Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Universität Freiburg, Albertstrasse 25, D-79104 Freiburg, Germany
Correspondence
Klaus Aktories
Klaus.Aktories{at}pharmakol.uni-freiburg.de
The pathogenicity of Clostridium difficile depends on the large clostridial glucosylating toxins A and B (TcdA and TcdB). The proteins accomplish their own uptake by a modular structure comprising a catalytic and a binding/translocation domain. Based on a proteolytic processing step solely the catalytic domain reaches the cytosol. Within the cells, the glucosyltransferases inactivate small GTPases by mono-O-glucosylation. Here, a short overview is given regarding latest insights into the intramolecular processing, which is mediated by an intrinsic protease activity.
This article has been cited by other articles:

|
 |

|
 |
 
I. R. Poxton
Clostridium difficile
J. Med. Microbiol.,
June 1, 2008;
57(6):
683 - 684.
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 Society for General Microbiology.